Skin homograft survival in cancer chemotherapy patients
- 1 September 1966
- Vol. 19 (9) , 1316-1320
- https://doi.org/10.1002/1097-0142(196609)19:9<1316::aid-cncr2820190921>3.0.co;2-y
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- PROLONGATION OF HOMOGRAFT SURVIVAL BY METHOTREXATE WITH PROTECTION AGAINST TOXICITY BY FOLINIC ACIDThe Lancet, 1964
- Persistent Mitosis of Transfused Homologous Leukocytes in Children Receiving Antileukemic TherapyScience, 1963
- Prolonged Survival of Human-Kidney Homografts by Immunosuppressive Drug TherapyNew England Journal of Medicine, 1963
- Preliminary CommunicationPublished by American Medical Association (AMA) ,1962
- THE REJECTION OF SKIN HOMOGRAFTS IN THE NORMAL HUMAN SUBJECT. PART I. CLINICAL OBSERVATIONS*Journal of Clinical Investigation, 1962
- Effect of 6‐Mercaptopurine Administration on Antibody Production and Clinical Course in Systemic Lupus Erythematosus. Report of a CaseArthritis & Rheumatism, 1961
- Investigations of Host Resistance in Cancer PatientsAnnals of Surgery, 1958
- Reduced Antibody Titers in Mice Treated with Carcinogenic and Cancer Chemotherapeutic AgentsExperimental Biology and Medicine, 1952
- THERAPEUTIC SUPPRESSION OF TISSUE REACTIVITYThe Lancet Healthy Longevity, 1951
- Inhibitory Effect of Nitrogen Mustard (Bis Beta-Chloroethyl Amine) on Lesions of Experimental Serum Hypersensitiveness.Experimental Biology and Medicine, 1949